Loading clinical trials...
Loading clinical trials...
The Relevance and Consistency Study of Changes in End Expiratory Lung Impedence Measured by EIT and End Expiratory Lung Volume Measured by Passive Expiratory in Controlled Mechanical Ventilated Exacerbation COPD Patients
The pathophysiological characteristics of respiratory failure on exacerbation of chronic pulmonary obstructive disease are the rapid deteriorate of respiratory symptoms, combined with aggravated flow limitation, gas trapping, dynamic pulmonary hyperinflation (DPH), therefore the intrinsic PEEP (PEEPi) increases. It is worthwhile to explore bedside methods to quantify the changes in dynamic pulmonary hyperinflation to guide safe and effective mechanical ventilation in airflow limited patients.
The study hypothesizes that the electrical impedence tomography (EIT) measured the changes of end expiratory lung impedence (△EELI) could accurately predict the changes of end expiratory lung volume (△EELV) measured by passive expiratory in controlled mechanical ventilated exacerbation COPD patients. The research intended to conduct a research to explore the relationship between △EELI and △EELV induced by external PEEP changes in ventilated exacerbation COPD patients.
Age
35 - 80 years
Sex
ALL
Healthy Volunteers
No
The First Affiliated Hospital of Guangzhou Medical
Guangzhou, Guangdong, China
Start Date
September 13, 2022
Primary Completion Date
October 8, 2023
Completion Date
October 8, 2023
Last Updated
November 22, 2022
10
ESTIMATED participants
the changes of end expiratory lung impedence
DIAGNOSTIC_TEST
the changes of end expiratory lung volume
DIAGNOSTIC_TEST
Lead Sponsor
The First Affiliated Hospital of Guangzhou Medical University
NCT07477600
NCT07462221
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions